Already popular in Europe, the Clearblue Advanced Pregnancy Test with Weeks Estimator has been given the green signal by the US Food and Drug Administration (FDA).
All home pregnancy tests are designed to detect the human chorionic gonadotropin (hCG) hormone, that women produce when they are pregnant, in the urine.
The new test contains two strips that measure hCG. One strip reads hCG levels to answer the question, "am I pregnant?"
So, if the test is positive, 'Pregnant' will be clearly indicated in words on the display along with an estimate of how many weeks have occurred since ovulation: 1-2 weeks, 2-3 weeks or 3+ weeks.
The Clearblue test estimates the weeks since ovulation with 93 per cent accuracy and is 99 per cent accurate for determining pregnancy, according to the product website.
The test will hit the stores and will be available online in US from next month.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
